Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
MOH — Molina Healthcare, Inc.
NYSE
FULL STOCK PAGE →

Molina Healthcare Q2 2026 Earnings Call Summary

JUL 23, 2026 2 MIN READ
REVENUE
$10.87B +0.7%
NET MARGIN
0.6% +0.4 PTS
EPS
$1.19 +340.7%
FREE CASH FLOW
-$324.0M -130.7%

1Key Financial Results and Metrics

Adjusted Earnings Per Share (EPS): $1.51

Premium Revenue: $10.2 billion

Consolidated Medical Care Ratio (MCR): 92.2%

Adjusted Pretax Margin: 1% for the quarter, 1.3% year-to-date

Medicaid MCR: 92.7%, in line with expectations; projected full-year MCR unchanged at 92.9%

Medicare MCR: 90.7%, better than expected; full-year guidance improved to 92.2%

Marketplace MCR: 88.9%, higher than expectations due to prior year items and unfavorable member acuity mix; full-year guidance revised to 90%

Full-Year Premium Revenue Guidance: Approximately $42 billion, unchanged

Revised Full-Year Adjusted EPS Guidance: Increased by $0.25 to at least $5.25

2Strategic Updates and Business Highlights

Medicaid and Medicare Growth: Strong performance in Medicaid and duals Medicare products; duals expected to contribute $1.25 per share.

RFP Wins: Retained significant contracts in Illinois and Wisconsin, enhancing the duals business.

M&A Activity: Active acquisition pipeline; looking for accretive opportunities in a challenging environment.

Operational Efficiency: Continued focus on cost management with G&A ratio at 6.5%.

3Forward Guidance and Outlook

2026 Guidance: EPS expected to be at least $5.25, with Medicaid margins projected to improve in 2027.

2027 Premium Revenue Outlook: Approximately $46.5 billion, reflecting an 11% year-over-year growth.

EPS Building Blocks for 2027: Expected to exceed $10 per share, driven by embedded earnings and operational leverage.

Long-Term Targets: Confident in achieving $64 billion in premium revenue by 2029.

4Bad News, Challenges, or Points of Concern

Marketplace Losses: Significant reduction in marketplace guidance from a gain of $0.75 to a loss of $0.75 due to prior year items and unfavorable member acuity mix.

Regulatory Headwinds: Anticipated declines in Medicaid membership due to work requirements and other regulatory changes, potentially impacting future revenue.

Acquisition Risks: The political and regulatory landscape may pose challenges in securing favorable rates and maintaining margins.

Member Acuity Issues: High-cost members retained without adequate risk adjustment, leading to increased medical expenses.

5Notable Q&A Insights

Marketplace Dynamics: The acuity shift in the marketplace was underestimated, leading to higher costs without corresponding risk adjustment.

Medicaid Rate Updates: Minimal off-cycle rate increases observed; guidance remains stable at 4% for the year.

Regulatory Impacts: States are expected to adapt to new Medicaid regulations, which may lead to gradual membership declines but manageable acuity shifts.

Cash Flow Management: Operating cash flow is less relevant; focus remains on dividend extraction from subsidiaries to support growth initiatives. This summary encapsulates Molina Healthcare's financial performance, strategic initiatives, and outlook while highlighting challenges and insights from the Q&A session.

SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT